Combination of albumin-bilirubin grade and platelets to predict a compensated patient with hepatocellular carcinoma who does not require endoscopic screening for esophageal varices
- 6 January 2018
- journal article
- research article
- Published by Elsevier BV in Gastrointestinal Endoscopy
- Vol. 88 (2), 230-239.e2
- https://doi.org/10.1016/j.gie.2017.12.023
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- The impact of esophagogastric varices on the prognosis of patients with hepatocellular carcinomaScientific Reports, 2017
- Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular CarcinomaGastroenterology, 2016
- Hepatic venous pressure gradient in the preoperative assessment of patients with resectable hepatocellular carcinomaJournal of Hepatology, 2015
- Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: A systematic review and meta‐analysisHepatology, 2015
- The Influence of Hepatitis B Viral Load and Pre-S Deletion Mutations on Post-Operative Recurrence of Hepatocellular Carcinoma and the Tertiary Preventive Effects by Anti-Viral TherapyPLOS ONE, 2013
- Diagnosing and monitoring cirrhosis: Liver biopsy, hepatic venous pressure gradient and elastographyGastroenterología y Hepatología, 2012
- Revising consensus in portal hypertension: Report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertensionJournal of Hepatology, 2010
- Hepatitis B and hepatocellular carcinomaHepatology, 2009
- Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studiesJournal of Hepatology, 2006
- Outcomes of Patients with Hepatocellular Carcinoma Presenting with Variceal BleedingThe American Journal of Gastroenterology, 2004